The contraceptive implant for long acting reversible contraception in patients undergoing first trimester medical termination of pregnancy

Sexual and Reproductive Healthcare

Volumn 1, Issue 3, 2010, Pages 105-109

  Church, E ^a   Sengupta, S ^a   Chia, K V ^a  

^a ROYAL BOLTON HOSPITAL   (United Kingdom)

Author keywords

Long acting reversible contraception (LARC); Medical termination of pregnancy; Subdermal implant

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; VAGINA BLEEDING;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GREAT BRITAIN; HUMANS; MIFEPRISTONE; MISOPROSTOL; OBSERVATION; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY, UNPLANNED; PROGESTINS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954804690     PISSN: 18775756     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.srhc.2010.02.002     Document Type: Article

References (16)

1. Abortion Act 1967. London: HMSO; 1967.
2. Department Of Health. Abortion statistics, England and Wales: 2008. London, UK: Department Of Health; 2009.
3. Schünmann C., Glasier A. Measuring pregnancy intention and its relationship with contraceptive use among women undergoing therapeutic abortion. Contraception 2006, 73:520-524.
4. Dawe F, Rainford L. Contraception and sexual health. London: Office for National Statistics; 2004.
5. Newton J., Newton P. Implanon - the single-rod subdermal contraceptive implant. J Drug Eval 2003, 1:181-218.
6. Shu-Rong Z., Huai-Mei Z., Shao-Zhen Q., Guo-Wei S., Kaper R.F. A long-term study of the efficacy and acceptability of a single rod hormonal contraceptive implant (Implanon) in healthy women in China. Eur J Contracept Reprod Health Care 1999, 4:85-93.
7. National Institute For Clinical Excellence. Long acting reversible contraception. Clinical guideline 30, 2005. London: National Institute for Clinical Excellence; http://www.nice.org.uk/Guidance/CG30.
8. UK Medical Eligibility Criteria. Faculty of sexual and reproductive healthcare of the Royal College of Obstetricians & Gynaecologists. http://www.ffprhc.org.uk/admin/uploads/UKMEC2009.pdf.
9. Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Clinical guidance on progestogen only implants. Faculty of Sexual and Reproductive Healthcare, 2008, updated 2009. http://www.ffprhc.org.uk/admin/uploads/CEUGuidanceProgestogenOnlyImplantsApril08.pdf.
10. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion (National Evidence Based Clinical Guideline Number 7). London, UK; 2004. http://www.rcog.org.uk/womens-health/clinical-guidance/care-women-requesting-induced-abortion.
11. Cohan C.L., Dunkel-Schetter C., Lydon J. Pregnancy decision making: predictors of early stress and adjustment. Psychol Women Q 1993, 17:223-239.
12. Kero A., Lalos A. Ambivalence - a logical response to legal abortion: a prospective study among women and men. J Psychosom Obstet Gynaecol 2000, 21:81-91.
13. Soderberg H., Andersson C., Janzon L., Sjoberg N.-O. Continued pregnancy among abortion applicants. Acta Obstet Gynecol Scand 1997, 76:942-947.
14. Alex L., Hammarstrm A. Women's experiences in connection with induced abortion - a feminist perspective. Scan J Caring Sci 2004, 18:160-168.
15. Das S., Adegbenro A., Ray S., Amu O. Repeat abortion: facts and issues. J Fam Plann Reprod Health Care 2009, 35(2):93-95.
16. Schunmann C., Glasier A. Specialist contraceptive counselling and provision after termination of pregnancy improves uptake of long-acting methods but does not prevent repeat abortion: a randomized trial. Hum Reprod 2006, 21(9):2296-2303.